Skip to main content
. Author manuscript; available in PMC: 2019 Aug 18.
Published in final edited form as: Microbiol Spectr. 2019 May;7(3):10.1128/microbiolspec.BAI-0024-2019. doi: 10.1128/microbiolspec.bai-0024-2019

FIGURE 3.

FIGURE 3

TB vaccines in the pipeline, undergoing phase 1 to 3 clinical trials. Current vaccine candidates in the pipeline include protein/adjuvant-based, attenuated/killed or cell extract-based, and viral vector-based vaccines.